Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
Is Nvidia's forthcoming DLSS 5, shown GTC 2026, a game-ethics question mark? Is it spectacular? Yes and yes. Here are my first impressions from a demo Nvidia showed me. I have been a technology ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results